Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions

International Journal of Cancer

Volumn 132, Issue 9, 2013, Pages 2087-2094

  Chaiwongkot, Arkom ^a,b   Vinokurova, Svetlana ^b   Pientong, Chamsai ^a   Ekalaksananan, Tipaya ^a   Kongyingyoes, Bunkerd ^a   Kleebkaow, Pilaiwan ^a   Chumworathayi, Bandit ^a   Patarapadungkit, Natcha ^a   Reuschenbach, Miriam ^b   Von Knebel Doeberitz, Magnus ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

human papillomavirus; methylation; p16INK4a; transformation

Indexed keywords

F FACTOR; HPV E2 PROTEIN; METHYL CPG BINDING PROTEIN 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CLINICAL ARTICLE; EPIGENETICS; FEMALE; HOST CELL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INVASIVE CARCINOMA; METHYLATION; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS GENOME; VIRUS ONCOGENE;

BINDING SITES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; DNA, VIRAL; FEMALE; GENOME, VIRAL; HUMANS; MUTATION; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; REGULATORY SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 84874110812     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27906     Document Type: Article

References (50)

1. McLaughlin-Drubin ME, Crum CP, Munger K,. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci USA 2011; 108: 2130-5.
2. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 1048-56.
3. zur Hausen H,. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994; 343: 955-7.
4. zur Hausen H,. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-50.
5. Bodily J,. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 2011; 19: 33-9.
6. Boyer SN, Wazer DE, Band V,. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996; 56: 4620-4.
7. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36.
8. von Knebel Doeberitz M, Reuschenbach M, Schmidt D, et al. Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections. Expert Rev Proteomics 2012; 9: 149-63.
9. Thierry F,. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009; 384: 375-9.
10. Romanczuk H, Thierry F, Howley PM,. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 1990; 64: 2849-59.
11. Rapp B, Pawellek A, Kraetzer F, et al. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J Virol 1997; 71: 6956-66.
12. Steger G, Corbach S,. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 1997; 71: 50-8.
13. Stubenrauch F, Lim HB, Laimins LA,. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J Virol 1998; 72: 1071-7.
14. Kalantari M, Blennow E, Hagmar B, et al. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 2001; 10: 46-54.
15. Luft F, Klaes R, Nees M, et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001; 92: 9-17.
16. Woodman CB, Collins SI, Young LS,. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007; 7: 11-22.
17. Dowhanick JJ,. Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 1995; 69: 7791-9.
18. Wells SI,. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J 2000; 19: 5762-71.
19. Jeon S, Allen-Hoffmann BL, Lambert PF,. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995; 69: 2989-97.
20. Jeon S, Lambert PF,. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 1995; 92: 1654-8.
21. Cullen AP, Reid R, Campion M, et al. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-12.
22. Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999; 59: 6132-6.
23. Pett M, Coleman N,. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 2007; 212: 356-67.
24. Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008; 68: 307-13.
25. Arias-Pulido H, Peyton CL, Joste NE, et al. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006; 44: 1755-62.
26. Baker CC, Phelps WC, Lindgren V, et al. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987; 61: 962-71.
27. Karlin S, Doerfler W, Cardon LR,. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 1994; 68: 2889-97.
28. Sanchez IE, Dellarole M, Gaston K, et al. Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res 2008; 36: 756-69.
29. Thain A, Jenkins O, Clarke AR, et al. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 1996; 70: 7233-5.
30. Kim K, Garner-Hamrick PA, Fisher C, et al. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 2003; 77: 12450-9.
31. Rosl F, Arab A, Klevenz B, et al. The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol 1993; 74: 791-801.
32. Badal V, Chuang LS, Tan EH, et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 2003; 77: 6227-34.
33. Piyathilake CJ, Macaluso M, Alvarez RD, et al. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer 2011; 117: 957-63.
34. Xi LF, Jiang M, Shen Z, et al. Inverse Association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLoS One 2011; 6: e23897.
35. Bhattacharjee B, Sengupta S,. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 2006; 354: 280-5.
36. Ding DC, Chiang MH, Lai HC, et al. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol 2009; 147: 215-20.
37. Fernandez AF, Rosales C, Lopez-Nieva P, et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 2009; 19: 438-51.
38. Kalantari M, Calleja-Macias IE, Tewari D, et al. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 2004; 78: 12762-72.
39. Van Tine BA, Kappes JC, Banerjee NS, et al. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 2004; 78: 11172-86.
40. Vinokurova S, von Knebel Doeberitz M,. Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One 2011; 6: e24451.
41. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-87.
42. Durst M, Kleinheinz A, Hotz M, et al. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 1985; 66: 1515-22.
43. Bhattacharjee B, Sengupta S,. HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women. Gynecol Oncol 2006; 100: 372-8.
44. Snellenberg S, Schutze DM, Claassen-Kramer D, et al. Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex(R) xMAP system. Virology 2011; 422: 357-65.
45. Duensing S, Munger K,. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 2004; 109: 157-62.
46. Bechtold V,. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol 2003; 77: 2021-8.
47. Schmidt MT, Olejnik AK, Gozdzicka-Jozefiak A,. The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome. Acta Biochim Pol 2005; 52: 823-32.
48. von Knebel Doeberitz M, Bauknecht T, Bartsch D, et al. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci USA 1991; 88: 1411-15.
49. Kalantari M, Lee D, Calleja-Macias IE, et al. Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 2008; 374: 292-303.
50. De-Castro AJ, Gockel-Krzikalla E, Rosl F,. Silencing of multi-copy HPV16 by viral self-methylation and chromatin occlusion: a model for epigenetic virus-host interaction. Hum Mol Genet 2012; 21: 1693-705.